REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,284.00
Bid: 1,284.00
Ask: 1,292.00
Change: -6.00 (-0.47%)
Spread: 8.00 (0.623%)
Open: 1,266.00
High: 1,302.00
Low: 1,266.00
Prev. Close: 1,290.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM & Q1 IMS

9 Feb 2018 07:00

RNS Number : 3712E
Victrex PLC
09 February 2018
 
 

 

9 February 2018

Victrex plc

AGM and Q1 Interim Management Statement

'A strong start to 2018'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first quarter (Q1) Interim Management Statement ahead of its Annual General Meeting (AGM) being held today.

Victrex made a strong start to its 2018 financial year, with a continuing positive performance in the Industrial business, offset by a slightly weaker performance in Medical.

Against a weaker comparative, Q1 revenue of £78.7m was 41% ahead of the prior year period (Q1 2017: £55.7m), with Q1 Group sales volume of 1,051 tonnes being 30% ahead of the prior year (Q1 2017: 810 tonnes).

Alongside continuing strength in Industrial, the Group's Q1 performance also reflects three specific items which were not in the comparative period. These are the benefit from currency hedges taken on at the most favourable post-Brexit rates; sales from our Zyex acquisition; and a sizeable proportion of volumes for the large Consumer Electronics order, compared to negligible volumes in Q1 2017. Excluding these items, our underlying momentum is broadly unchanged from the positive performance we saw in the second half of 2017.

Victrex saw good performances across most end markets, with Electronics being the strongest performer and a steady start in Aerospace. Medical saw a weaker end to the quarter, although we continue to see progress in our innovative PEEK-OPTIMATM HA Enhanced product for the Spine market and outside the US.

Our pipeline of new products remains strong. We have now started supplying the first parts for our Gears mega-programme to a major European car manufacturer, whilst in Magma, a deployment of a 2.5km flowline by Tullow Oil in West Africa supports our expectations of growth this year.

Victrex retains a highly cash generative business model, with no change to its financial position since 30 September 2017. Currency remains supportive for 2018, with the most favourable currency rates coming through in the first half and a heavy bias towards Q1. Looking further ahead, Sterling's re-rating currently implies an increasing headwind for 2019.

Outlook

Jakob Sigurdsson, Chief Executive of Victrex, said: "Victrex has made a strong start to 2018. If the strength in our Industrial business continues to offset weakness in Medical, it could offer a limited degree of upside potential to expectations, although it remains very early in the year and our underlying momentum is broadly unchanged from the second half of 2017.

"Our priorities for 2018 are to remain focused on driving growth, on cost efficiency and to show further progress in our Polymer & Parts strategy."

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 7809 595831

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 08.30am GMT. Dial in details +44 (0) 3333 000804 PIN: 22224538#

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSFFMAFASEDE
Date   Source Headline
7th May 20243:25 pmRNSDirector Declaration
30th Apr 20242:54 pmRNSTotal Voting Rights
28th Mar 20249:56 amRNSTotal Voting Rights
15th Mar 20248:30 amRNSDirectorate Change
6th Mar 20242:06 pmRNSDirector/PDMR Shareholding
29th Feb 20249:36 amRNSTotal Voting Rights
21st Feb 20248:00 amRNSBlock listing Interim Review
9th Feb 202412:16 pmRNSResult of AGM
9th Feb 20247:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202412:26 pmRNSTotal Voting Rights
25th Jan 202410:57 amRNSHolding(s) in Company
9th Jan 202412:13 pmRNSAnnual Report & Accounts
29th Dec 20239:00 amRNSTotal Voting Rights
12th Dec 202310:21 amRNSDirector/PDMR Shareholding
5th Dec 20232:42 pmRNSDirector/PDMR Shareholding
5th Dec 20232:33 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSVictrex plc - Preliminary Results 2023
1st Dec 202310:41 amRNSBlock listing Interim Review
30th Nov 202311:10 amRNSTotal Voting Rights
3rd Nov 20231:31 pmRNSHolding(s) in Company
31st Oct 20239:36 amRNSTotal Voting Rights
19th Sep 20231:59 pmRNSDirector/PDMR Shareholding
8th Sep 20239:32 amRNSHolding(s) in Company
31st Aug 20239:30 amRNSTotal Voting Rights
23rd Aug 202310:52 amRNSHolding(s) in Company
17th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20239:39 amRNSTotal Voting Rights
18th Jul 202311:51 amRNSDirector/PDMR Shareholding
13th Jul 20232:00 pmRNSAdditional Listing
6th Jul 20237:00 amRNSVictrex plc - Q3 Interim Management Statement
3rd Jul 20234:03 pmRNSHolding(s) in Company
30th Jun 20239:37 amRNSTotal Voting Rights
27th Jun 202310:08 amRNSDirector/PDMR Shareholding
19th Jun 20232:27 pmRNSDirector/PDMR Shareholding
14th Jun 20237:00 amRNSTrading Statement
1st Jun 202312:08 pmRNSBlock listing Interim Review
31st May 20239:52 amRNSTotal Voting Rights
17th May 202310:55 amRNSDirector/PDMR Shareholding
16th May 202310:03 amRNSDirector/PDMR Shareholding
12th May 202310:37 amRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
10th May 20231:34 pmRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSVictrex plc - Interim Results 2023
28th Apr 20239:33 amRNSTotal Voting Rights
18th Apr 20232:00 pmRNSHolding(s) in Company
18th Apr 202310:50 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSDirectorate Change
31st Mar 202310:52 amRNSTotal Voting Rights
20th Mar 20233:07 pmRNSHolding(s) in Company
20th Mar 202310:15 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.